Using Social Media to Promote Cutting-edge Research in Transplantation: Results of an International Survey-Reference-Cited by-同舟云学术

Using Social Media to Promote Cutting-edge Research in Transplantation: Results of an International Survey

Published:2023-06-13 Issue:11 Volume:107 Page:2294-2297
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Atif Mo¹,Kaplow Katya N.²,Akhtar Jasmine M.²,Sidoti Carolyn N.²,Li Jennifer³⁴,Au Eric H.K.⁵⁶⁷,Baan Carla C.⁸,Levan Macey L.²⁹

Affiliation:

1. Department of General Surgery, University Hospitals Birmingham, Birmingham, United Kingdom.

2. Department of Surgery, NYU Grossman School of Medicine, NYU Langone Health, New York, NY.

3. Centre for Transplant and Renal Research, Westmead Hospital, Westmead, NSW, Australia.

4. Westmead Institute for Medical Research, Westmead, NSW, Australia.

5. Department of Renal Medicine, The Alfred Hospital, Melbourne, VIC, Australia.

6. Central Clinical School, Monash University, Melbourne, VIC, Australia.

7. Sydney School of Public Health, The University of Sydney, Sydney, NSW, Australia.

8. Department of Internal Medicine, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.

9. Department of Population Health, NYU Grossman School of Medicine, New York, NY.

Abstract

Funder

NIH

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference17 articles.

1. Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination.;Chiang;Am J Transplant,2022

2. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial.;Messchendorp;Lancet Infect Dis,2022

3. Immune response after the fourth dose of SARS-CoV-2 mRNA vaccine compared to natural infection in three doses’ vaccinated solid organ transplant recipients.;Busa;Viruses,2022

4. SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.;Perrier;Vaccine,2022

5. A fourth dose of COVID-19 vaccine does not induce neutralization of the omicron variant among solid organ transplant recipients with suboptimal vaccine response.;Karaba;Transplantation,2022